OSL oncosil medical ltd

Their reporting of the outcomes is inconsistent. We have: -...

  1. 37 Posts.
    lightbulb Created with Sketch. 6
    Their reporting of the outcomes is inconsistent.
    We have:
    - early and substantial tumour volumetric reduction observed in participants at 4 weeks after implantation
    - Disease Control Rate (DCR) at Week 8 was 100%

    Why not DCR at 4 weeks or volumetric reduction at 8 weeks? More to the point, why not either of these outcomes past 8 weeks?

    Presumably there will be a more thorough results report at some point in the future - as is they could be accused of cherrypicking the positives.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.08
Change
-0.050(4.42%)
Mkt cap ! $20.33M
Open High Low Value Volume
$1.15 $1.15 $1.08 $45.62K 40.76K

Buyers (Bids)

No. Vol. Price($)
3 718 $1.08
 

Sellers (Offers)

Price($) Vol. No.
$1.10 2361 1
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.